• Immunodeficiency and viral clearance and evolution - JAMA, STAT , MGB Press release

• Virological rebound in 1 out of 5 people taking Paxlovid - TIME, STAT, Healio, New Scientist, HealthDay, Harvard Gazette, Medscape, MedPage Today

• Viable virus shedding in SARS-CoV-2 omicron/delta - New York Times (behind paywall), NPR, Nature News, Washington Post, Boston.com, UpToDate

• Rebound after Paxlovid treatment study - Boston Globe, Scientific American

• Immunodeficiency and viral clearance and evolution Science Translational Medicine article discussed on TWIV 1085 (starts ~ 28:49)

• Annals of Internal Medicine SARS-CoV-2 virology rebound paper discussed on The Colin McEnroe Show, TWIV 1062, Annals On Call

• NEJM Viable virus shedding in SARS-CoV-2 omicron/delta paper discussed on TWiV 916 (starts at 31:00) and Editorial NEJM interview (Start ~8:15)

• Initial virological rebound after Paxlovid treatment CID paper discussed on TWIV 905

• Immunodeficiency and viral clearance Science Translational Medicine article designated as “January 2024- Article of the Month” by the American Society of Transplantation

• Virology Rebound after Paxlovid treatment paper selected as one of the most influential article of 2023 in Annals of Internal Medicine.